Psychedelic therapy: Fresh promise for mental health
Heidi Bush
Mental Health Weekly January 24, 2020 DOI: 10.1002/mhw.32207 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | LSD Psilocybin Psychedelic-assisted therapy |
| Keywords | Psychotherapist Mental health Depression economics Hallucinogen |
| Key findings | Psychedelic-assisted psychotherapy is seeing a resurgence as a treatment approach for mental health disorders. |
Abstract
Psychedelic‐assisted psychotherapy is seeing a resurgence as a treatment approach for mental health disorders. It melds pharmacology and psychotherapy, using substances such as lysergic acid diethylamide (LSD) and psilocybin, under medical supervision, to treat conditions such as post‐traumatic stress disorder (PTSD) and extreme depression.
Comparable studies
Other narrative reviews on LSD and psychedelic-assisted therapy, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications Participants in psychedelic therapy research aged 18–69 with varied backgrounds | 2020 | Rapid review | n = 180 |
| Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness. Palliative care clinicians and patients | 2022 | Review | |
| Psychedelic drugs for psychiatric disorders. | 2022 | Review | |
| The Efficacy of Psychedelic-Assisted Therapy in Managing Post-traumatic Stress Disorder (PTSD): A New Frontier? | 2022 | Review | |
| Psychedelic Therapy: A Primer for Primary Care Clinicians-Lysergic Acid Diethylamide (LSD). | 0 | Review |